Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication in NAFLD
NCT01759628Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2012
- Primary completion
- Jun 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of omeprazole, amoxicillin, bismuth subcitrate, clarithromycin in Helicobacter pylori infection, sponsored by Tehran University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
omeprazoleamoxicillinbismuth subcitrateclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01759628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759628.